IL211681A0 - Modified release emulsions for application to skin or vaginal mucosa - Google Patents

Modified release emulsions for application to skin or vaginal mucosa

Info

Publication number
IL211681A0
IL211681A0 IL211681A IL21168111A IL211681A0 IL 211681 A0 IL211681 A0 IL 211681A0 IL 211681 A IL211681 A IL 211681A IL 21168111 A IL21168111 A IL 21168111A IL 211681 A0 IL211681 A0 IL 211681A0
Authority
IL
Israel
Prior art keywords
skin
application
modified release
vaginal mucosa
release emulsions
Prior art date
Application number
IL211681A
Other languages
English (en)
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40340663&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL211681(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of IL211681A0 publication Critical patent/IL211681A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
IL211681A 2008-10-08 2011-03-10 Modified release emulsions for application to skin or vaginal mucosa IL211681A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08166058A EP2174650A1 (en) 2008-10-08 2008-10-08 Modified release emulsions for application to skin or vaginal mucosa
PCT/EP2009/062190 WO2010040632A1 (en) 2008-10-08 2009-09-21 Modified release emulsions for application to skin or vaginal mucosa

Publications (1)

Publication Number Publication Date
IL211681A0 true IL211681A0 (en) 2011-06-30

Family

ID=40340663

Family Applications (1)

Application Number Title Priority Date Filing Date
IL211681A IL211681A0 (en) 2008-10-08 2011-03-10 Modified release emulsions for application to skin or vaginal mucosa

Country Status (19)

Country Link
US (1) US20110195944A1 (enExample)
EP (2) EP2174650A1 (enExample)
JP (1) JP2012505171A (enExample)
KR (1) KR20110067115A (enExample)
CN (1) CN102170862A (enExample)
AR (1) AR073801A1 (enExample)
AU (1) AU2009301275A1 (enExample)
BR (1) BRPI0920565A2 (enExample)
CA (1) CA2737255A1 (enExample)
CL (1) CL2011000767A1 (enExample)
CO (1) CO6361898A2 (enExample)
EA (1) EA201170555A1 (enExample)
IL (1) IL211681A0 (enExample)
MA (1) MA32687B1 (enExample)
MX (1) MX2011003696A (enExample)
NZ (1) NZ591919A (enExample)
PE (1) PE20110449A1 (enExample)
WO (1) WO2010040632A1 (enExample)
ZA (1) ZA201101818B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2667852B1 (en) * 2011-01-27 2016-11-09 GlaxoSmithKline Biologicals SA Adjuvant nanoemulsions with crystallisation inhibitors
WO2012135422A2 (en) * 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
DE102011076869A1 (de) * 2011-06-01 2012-12-06 Beiersdorf Ag Emulsionszubereitungen mit verbesserten rheologischen Eigenschaften
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
CN104105472A (zh) 2011-12-20 2014-10-15 维奥姆生物科学有限公司 用于治疗真菌感染的局部油组合物
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN105263525A (zh) * 2013-04-12 2016-01-20 维奥姆生物科学有限公司 抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法
AU2015229421B2 (en) * 2014-03-12 2020-06-04 Allergan Therapeutics LLC Low-dose estradiol cream
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11026883B2 (en) * 2016-10-13 2021-06-08 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
KR20250024864A (ko) * 2017-06-22 2025-02-19 비라말 리미티드 약물 전달을 위한 조성물 및 그의 사용 방법
WO2019213473A1 (en) 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1349545T3 (da) * 2000-12-05 2009-02-16 Los Angeles Childrens Hospital Farmaceutiske præparater af fenretinid med öget biotilgængelighed samt fremgangsmåder til anvendelse deraf
CA2480225A1 (en) * 2002-04-04 2003-10-16 Eugene H. Gans Methods for treating rosacea with pyridones
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20040087564A1 (en) * 2002-10-31 2004-05-06 Wright D. Craig Delivery composition and method
WO2007099396A2 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US20080075745A1 (en) * 2006-09-21 2008-03-27 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions containing ciclopirox or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
MA32687B1 (fr) 2011-10-02
CL2011000767A1 (es) 2011-06-17
NZ591919A (en) 2012-09-28
AU2009301275A2 (en) 2011-04-28
ZA201101818B (en) 2012-05-30
WO2010040632A1 (en) 2010-04-15
US20110195944A1 (en) 2011-08-11
JP2012505171A (ja) 2012-03-01
CN102170862A (zh) 2011-08-31
KR20110067115A (ko) 2011-06-21
AR073801A1 (es) 2010-12-01
PE20110449A1 (es) 2011-07-07
BRPI0920565A2 (pt) 2015-12-29
EA201170555A1 (ru) 2011-12-30
EP2174650A1 (en) 2010-04-14
MX2011003696A (es) 2011-06-20
CO6361898A2 (es) 2012-01-20
AU2009301275A1 (en) 2010-04-15
CA2737255A1 (en) 2010-04-15
EP2331065A1 (en) 2011-06-15

Similar Documents

Publication Publication Date Title
IL211681A0 (en) Modified release emulsions for application to skin or vaginal mucosa
EP2389100A4 (en) SYSTEM FOR THE NON-EFFRACTIVE DETERMINATION OF ALCOHOL IN A FABRIC
BR112012004166A2 (pt) colocação otimizada de cândula para aplicação de agentes terapêuticos ao cérebro
SG10201608068SA (en) Compositions And Methods For Skin Care
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI0911290A2 (pt) âncora universal para ligar objetos ao tecido ósseo
BRPI0914630A2 (pt) liberação dérmica
SG10201503135RA (en) Agent for treating disease
IL207892A0 (en) Agent for treating disease
IL207891A0 (en) Agent for treating disease
GB0715556D0 (en) Improvements relating to skin dressings
GB0909840D0 (en) Thermal tramsfer device for human body
PT2280717T (pt) Agente terapêutico para doenças anaeróbias
LT2400943T (lt) Kosmetinė arba farmacinė emulsija odai, sumaišytina prieš pat naudojimą
BRPI0913337A2 (pt) liberação pulsátil de valsartan
GB0902040D0 (en) Composition for treatment of skin
PL2148676T3 (pl) Stosowanie sapacytabiny do leczenia choroby proliferacyjnej
EP2123254A4 (en) COMPOSITION FOR EXTERNAL APPLICATION TO THE SKIN
EP2334353A4 (en) USE OF SCHOOL TREATMENT FOR DISEASE TREATMENT
EP2221040A4 (en) COMPOSITION FOR TOPICAL APPLICATION TO THE SKIN
GB2447884B (en) Treatment for skin disease
GB2446447B (en) Tissue tensiometer
EP2123251A4 (en) COMPOSITION FOR EXTERNAL APPLICATION TO THE SKIN
TWI371289B (en) Mixture for skin care
EP2305654A4 (en) THERAPEUTIC AGENT AGAINST PAIN